In the present study, our data showed that TOPK was mainly increased in epidermal keratinocytes and post-application of TOPK inhibitor OTS514 significantly attenuated psoriasis-like manifestations and pathological changes in already-established psoriatic model mice. This evidence concerns the gene PBK and psoriasis.